[333 Pages Report] The global myopia and presbyopia treatment market is expected to reach a market valuation of US$ 17.9 Billion by the year 2022, accelerating with a CAGR of 8.5% by 2022-2032. The myopia and presbyopia treatment market share is anticipated to be valued at about US$ 40.5 Billion by 2032 end.
Soaring myopia-related vision loss incidences and the frequency of myopia-related distant visual impairments are two of the key reasons that are anticipated to boost the myopia and presbyopia treatment market share. Secondly, during the course of the forthcoming years, the myopia and presbyopia market size is anticipated to rise given the increasing prevalence of nearsightedness on a massive level.
| Attributes | Value |
|---|---|
| Myopia and Presbyopia Treatment Market Size (2022) | US$ 17.9 Billion |
| Myopia and Presbyopia Treatment Market Projected Size (2032) | US$ 40.5 Billion |
| Myopia and Presbyopia Treatment Market Growth CAGR (2022 to 2032) | 8.5% |
According to the global market study on myopia and presbyopia treatment services, around the world, presbyopia affected more than 2.1 Billion people in the year 2020. As per the estimates of UN World Health Organization (WHO), untreated presbyopia affected over 826 Million of people globally in the year 2020. Consequently, over the projection period, it is anticipated that the emerging nations would see a considerable development in the adoption of myopia and presbyopia treatment services.
Elderly people those are in their early 40s and the expanding aging population who are at risk for eyesight loss—are majorly driving the myopia and presbyopia treatment market growth. Moreover, it is expected that the demand for myopia and presbyopia treatment might increase as the imbalanced lifestyle of a large section of society results in many kind of eyesight problem conditions.
Corneal inlays are an additional cutting-edge alternative for people with presbyopia which in turn is emerging as the major attraction in the global myopia and presbyopia market share. Besides, the advent of cutting-edge lenses namely implantable contact lenses and intraocular phakic intraocular lenses (PIOL) is anticipated to propel the myopia and presbyopia treatment market trends in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
“On account of modern day breakthroughs in ocular lenses, it is anticipated the emerging trends in myopia and presbyopia treatment services would be instrumental in popularizing the market.”
Internationally, there is a huge surge in the need for treatment choices including contact, concave, or prescription lenses that is anticipated to strengthen the global demand for myopia and presbyopia treatment facilities. The healthcare sector of various nations are also concentrating on enhancing patient flow, and as a result, they are also thinking about expanding the number of myopia and presbyopia treatment clinics.
Amongst the most cutting-edge methods for treating presbyopia is presbyLASIK OR multifocal LASIK that is anticipated to steer the myopia and presbyopia treatment market future trends ahead. However, despite the convenience of modern day LASIK surgeries, the myopia and presbyopia treatment market opportunities is also expected to strengthen for patients experiencing dry eyes condition.
Untreated presbyopia is one of the main issues that will have a significant limiting effect on the global myopia and presbyopia market. Many individuals still don't understand the aetiology of presbyopia, which leads to delayed diagnoses and less adoption of myopia and presbyopia treatment services.
Hardly two corneal inlays have been given approval to treat presbyopia at this time posing as a major restraint for the overall myopia and presbyopia market growth. However, the myopia and presbyopia market key trends and opportunities is anticipated to be aided by an expanding product portfolio and an increase in active innovations in the coming days.
Principal Consultant
“Over the years of myopia and presbyopia treatment market adoption trends, the typical recovery period for ocular procedures has been drastically shortened, thanks to cutting-edge technological solutions.”
In conformity with the myopia and presbyopia market statistics, the sector with the highest revenue share by the end of year 2021— accounting for more than 30% is the single prescription lenses. Reason being, in recent years myopia treatment is getting more common in emerging nations with the rising need for corrective lenses. The patient base has expanded considerably, which is helping to boost the myopia and presbyopia market size by contribution of the single prescription lenses market segment.
On the other hand, the popularity of the surgical procedures is being influenced by its attributes including minimally invasiveness, precision, and speed. Consequently, encouraging the demand for myopia and presbyopia treatment services for this segment. During the projection period of 2022 to 2032, there will likely be an upward turn in myopia ad presbyopia market trends and forecast owing to increasing popularity of surgery segment with the readily available cutting-edge equipment and dropping service prices.
On the report of myopia and presbyopia treatment market survey until 2021, the most significant revenue share—more than 25%—was captured by prescription lenses segment. Additionally, bifocal, multifocal, monovision, and modified monovision contact lenses fall within these categories constituting the sub-segments covered by this myopia and presbyopia market analysis report.
Presbyopia can be effectively treated using conductive keratoplasty surgery, LASIK, LASEK, and PRK, among other refractive surgical techniques that have started contributing to the myopia and presbyopia market growth remarkably in recent times. The surgical procedure segment or LASIK is extensively used to cure presbyopia in high income countries.
Therefore, it is anticipated that the rapid spread of these presbyopia treatment options and growing preference for LASIK surgery would promote the all-inclusive myopia and presbyopia treatment business throughout the course of the projection period.
All things considered, due to the rising popularity of correcting presbyopia, the progressive multifocal section is anticipated to see the quickest growth over the course of the projected period. Additionally, throughout the forecast period, multifocal sub segments including those with photochromic lenses and anti-reflexive coatings are anticipated to drive the overarching myopia and presbyopia market growth
Owing to the accessibility of cutting-edge technologies for managing the various targeted myopia treatment types, as well as the presence of numerous market players, North America holds the leading position in the overall market with a capitalization of over 20.0%. And therefore, this region, particularly US myopia and presbyopia treatment market is anticipated to maintain its dominance over the course of the forecast period.
On a similar note, presbyopia affects around 128 Million individuals in the United States only. And one-third of these people come under above 50 years age group bracket.
Due to the enlarging senior population count, the high prevalence of myopia-related eye treatments, and the rise in healthcare services, the Asia Pacific region is anticipated to see the sharpest growth in myopia and presbyopia treatment market trends throughout the projected period.
The market for myopia and presbyopia treatments in the regional market is anticipated to be driven by consumers' improving understanding of focused myopia therapy. Additionally, the regions comprising East Asia, South Asia, and Southeast Asia have the highest rates of vision problems that amounts to more than twice as many cases as other areas.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Myopia and presbyopia treatment market participants are concentrating on implementing growth initiatives, such as improvements to current technology, introduction of effective procedures, and consolidations. Myopia and presbyopia market leaders are also planning for investments in R&D to facilitate early diagnosis and create effective and speedy operating approaches to guarantee field uniqueness and solidify their market position.
Major myopia and presbyopia treatment companies like Johnson & Johnson, Essilor, and Zeimer Ophthalmic Systems AG are increasing their partnerships to create cutting-edge methodologies and therapeutic approaches to deliver better and more effective therapy for myopia and presbyopia patients.
Recent Developments in Global Myopia and Presbyopia Treatment Market
The myopia and presbyopia treatment market is expected to grow at 8.5% CAGR over 2022-2032.
The myopia and presbyopia treatment market is estimated to be around US$ 17.9 Billion in 2022.
The myopia and presbyopia treatment market is anticipated to reach a valuation of US$ 40.5 Billion by 2032.
The single prescription treatment segments contributes almost 30%.
North America is the most lucrative region for myopia and presbyopia treatment market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Treatment Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Treatment Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment Type, 2022-2032
5.3.1. Myopia
5.3.1.1. Corrective
5.3.1.1.1. Prescription Lenses
5.3.1.1.1.1. Single
5.3.1.1.1.2. Bifocal
5.3.1.1.1.3. Trifocal
5.3.1.1.1.4. Other Prescription Lenses
5.3.1.1.2. Contact Lenses
5.3.1.2. Surgical
5.3.1.3. Drugs
5.3.2. Presbyopia
5.3.2.1. Prescription Lenses
5.3.2.1.1. Reading Glasses
5.3.2.1.2. Bifocals
5.3.2.1.3. Trifocals
5.3.2.1.4. Progressive Multifocals
5.3.2.1.5. Office Progressives
5.3.2.2. Contact Lenses
5.3.2.2.1. Bifocal
5.3.2.2.2. Multifocal
5.3.2.2.3. Monovision
5.3.2.2.4. Modified Monovision
5.3.2.3. Intraocular Lenses
5.3.2.4. Refractive Surgery
5.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Treatment Type, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Treatment Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Treatment Type
7.4. Key Takeaways
8. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Treatment Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Treatment Type
8.4. Key Takeaways
9. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Treatment Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment Type
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Treatment Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment Type
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Treatment Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment Type
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2021
12.1.2.1. By Treatment Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2021
12.2.2.1. By Treatment Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2021
12.3.2.1. By Treatment Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2021
12.4.2.1. By Treatment Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2021
12.5.2.1. By Treatment Type
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2021
12.6.2.1. By Treatment Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2021
12.7.2.1. By Treatment Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2021
12.8.2.1. By Treatment Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2021
12.9.2.1. By Treatment Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2021
12.10.2.1. By Treatment Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2021
12.11.2.1. By Treatment Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2021
12.12.2.1. By Treatment Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2021
12.13.2.1. By Treatment Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2021
12.14.2.1. By Treatment Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2021
12.15.2.1. By Treatment Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2021
12.16.2.1. By Treatment Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2021
12.17.2.1. By Treatment Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2021
12.18.2.1. By Treatment Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2021
12.19.2.1. By Treatment Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Treatment Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Zeimer Ophthalmic Systems AG
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. NIDEK CO. LTD.
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Johnson & Johnson Vision
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. ZEISS International
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. ALCON VISION LLC
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Bausch & Lomb Incorporated
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Haag-Streit UK
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Topcon Corporation
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Essilor Ltd.
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Healthcare Insights
View Reports
Myopia and Presbyopia Treatment Market
